Raul Ortega, MD
Vascular Surgery · Denton, TXNPI 1295902385
Payments from drug & device makers
Across 181 payments — averaging $46.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$2K
- Endologix LLC$1K
- Inari Medical, Inc.$1K
- Tactile Systems Technology Inc$666
- Lemaitre Vascular, Inc.$632
- Silk Road Medical, Inc.$568
- plus $2K from 24 others
What the payments were for
- Consulting fees$5006%
- Food & beverage$7,88494%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 45 | $2,340 |
| Endologix LLC | 13 | $1,208 |
| Inari Medical, Inc. | 4 | $1,142 |
| Tactile Systems Technology Inc | 39 | $666 |
| Lemaitre Vascular, Inc. | 7 | $632 |
| Silk Road Medical, Inc. | 17 | $568 |
| Bolton Medical Inc | 6 | $299 |
| Stryker | 2 | $256 |
| Novartis | 8 | $161 |
| Penumbra, Inc. | 1 | $153 |
| Johnson & Johnson(2 entities) | 8 | $134 |
| Laminate Medical Technologies Inc. | 1 | $130 |
| Cook Medical LLC | 4 | $111 |
| Medtronic | 4 | $85 |
| Atricure, Inc. | 2 | $69 |
| Imperative Care, Inc | 2 | $60 |
| Smith+Nephew | 3 | $55 |
| Reflow Medical Inc | 2 | $47 |
| Pfizer | 2 | $44 |
| Abiomed | 1 | $35 |
| Pacira Pharmaceuticals Incorporated | 1 | $34 |
| Ossur Americas, Inc. | 1 | $25 |
| Terumo Medical Corporation | 1 | $20 |
| KCI USA, Inc. | 1 | $19 |
| Shockwave Medical, Inc | 1 | $18 |
| Cvrx, Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Cardinal Health 200 LLC | 1 | $16 |
| Cashflow Solutions, LLC | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$1,826
- ENDOCROSS Device$618
- Torus Stent Graft System$618
- XENOSURE$500
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$447
- C3 Delivery System$414
- ENROUTE Transcarotid Stent$290
- ENROUTE Transcarotid Neuroprotection System$290
- Alto Abdominal Stent Graft System$212
- GORE TAG Conformable Thoracic Endoprosthesis$200
- CT THROMBECTOMY SYSTEM KIT$197
- EXCLUDER Iliac Branch Endoprosthesis$190
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$157
- RUBY Coil$153
- CLOTTRIEVER BOLD CATHETER$145
- TREO ABDOMINAL STENT-GRAFT SYSTEM$136
- VasQ$130
- FlowTriever$111
How this compares
$8,384 in reported general payments places this provider in the 55th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 90 | $63,460 |
| EliquisApixaban | 37 | $30,649 |
| ClopidogrelClopidogrel Bisulfate | 179 | $1,175 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $322 |
| Rosuvastatin Calcium | 36 | $232 |
| Ibuprofen | 46 | $196 |
| Gabapentin | 16 | $167 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $134 | $63,46090 claims |
| PfizerEliquis | $44 | $30,64937 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 347 vascular surgery providers in Texas.
Other vascular surgery in Denton
- Mazin FotehAustin$2.5M
- Alan LumsdenHouston$2.4M
- Gregory PearlDallas$2.3M
- Gustavo OderichHouston$999K
- Michael SiahDallas$838K
- Stephen HohmannDallas$587K
- Dennis GableDallas$547K
- Carlos TimaranDallas$527K
- Samuel LeonardHouston$431K
- Ali AzizzadehHouston$387K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.